Seeking Alpha

Microcap bioresearch firm Adventrx Pharmaceuticals (ANX -1.1%) is lower today after the FDA says...

Microcap bioresearch firm Adventrx Pharmaceuticals (ANX -1.1%) is lower today after the FDA says the company will need to repeat a study of its lung-cancer treatment Exelbine because it can't verify the authenticity of certain drugs in the previous trial. The shares have been pummeled this year, down nearly 78% since mid-July.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|